DBV Technologies launches an ATM financing program

DBV Technologies has filed a prospectus for an At-The-Market (ATM) program with a potential value of up to $150 million. This filing was made with the SEC to renew the initial program in collaboration with Citizens JMP Securities, LLC. The sales will consist of American Depositary Shares (ADSs), with each ADS representing five common shares of the Company.

The proceeds from these sales will primarily be used to fund the expansion of manufacturing capacity, licensing applications for VIASKIN® Peanut for children, and other development projects. This program is not intended for the European public, in accordance with applicable regulations.

The registration statement took effect immediately, and the program terms remain unchanged. The full document, including risks and expectations, is available on the SEC website.